Skip to main content
16 Feb | 2022

Natàlia Vilor and Oriol Grau receive the Juan de la Cierva scholarship

Juan de la Cierva-Incorporación grants, awarded by the State Research Agency, fund postdoctoral research training in Spanish research centers for three years.

11 Feb | 2022

Oriol Grau, appointed head of the Clinical Research Group and in Risk Factors for Neurodegenerative Diseases

The Clinical Research Group on Risk Factors for Neurodegenerative Diseases will promote research, from an integrative and clinical perspective, in the prevention of Alzheimer's disease and research on healthy aging.

11 Feb | 2022

Gemma Salvadó receives a National Award for the best doctoral thesis on Diagnostic Imaging and Genomics from the QUAES Foundation

Gemma Salvadó joined the BBRC Neuroimaging Group in 2017 as a pre-doctoral researcher, where she collaborated until 2021. She is currently continuing her research on Alzheimer’s at Lund University (Sweden).

11 Feb | 2022

The FPM and the BBRC, with the International Day of Women and Girls in Science

Once again, we support women’s awareness-raising activities in science.

22 Nov | 2021

We detect that music related to life experiences activates parts of the brain other than those involved in the natural process of remembering.

A work led at the Barcelonaβeta Brain Research Center (BBRC), our research center, has studied the relationship between music and autobiographical memories.

18 Nov | 2021

Betascreen is born, the first spin-off of the Pasqual Maragall Foundation for the detection of Alzheimer's in the preclinical phase

A technology company promoted by the Barcelonaβeta Brain Research Center (BBRC) in conjunction with the researchers Dr. Juan Domingo Gispert and Dr. José Luis Molinuevo.

17 Nov | 2021

The Barcelonaβeta Brain Research Center launches a laboratory for the early detection of Alzheimer's with a blood test

Dr. Marc Suárez-Calvet, head of the Biomarkers in Fluids and Traslational Neurology group, will lead the new center aimed at developing, validating and applying new biomarkers for Alzheimer's disease.

19 Oct | 2021

Identified in the blood a biomarker that allows to detect in a very precise way the initial phases of the Alzheimer’s disease

Researchers at the Pasqual Maragall Foundation's research center, the Barcelonaβeta Brain Research Center (BBRC), with the support of the “la Caixa” Foundation, have detected that the glial fibrillar acid protein (GFAP) is a very accurate biomarker for diagnosing in blood the early stages of Alzheimer’s disease. 

08 Oct | 2021

BBRC researchers collaborate in a study from the Hospital del Mar that changes the approach to preventive treatment of brain metastasis in lung cancer

The research team in Neuroimage, guided by Dr. Juan Domingo Gispert, has participated in the study.